BIOVF Statistics
Total Valuation
BIOVF has a market cap or net worth of 14.15 billion. The enterprise value is 15.28 billion.
| Market Cap | 14.15B |
| Enterprise Value | 15.28B |
Important Dates
The next confirmed earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 345.66M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 42.85% |
| Float | 221.73M |
Valuation Ratios
The trailing PE ratio is 272.82 and the forward PE ratio is 20.20.
| PE Ratio | 272.82 |
| Forward PE | 20.20 |
| PS Ratio | 4.62 |
| PB Ratio | 3.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.30 |
| P/OCF Ratio | 15.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.25, with an EV/FCF ratio of 16.53.
| EV / Earnings | 294.74 |
| EV / Sales | 4.98 |
| EV / EBITDA | 12.25 |
| EV / EBIT | 17.58 |
| EV / FCF | 16.53 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.90 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.00 |
| Debt / FCF | 1.35 |
| Interest Coverage | 9.63 |
Financial Efficiency
Return on equity (ROE) is 1.22% and return on invested capital (ROIC) is 16.55%.
| Return on Equity (ROE) | 1.22% |
| Return on Assets (ROA) | 7.00% |
| Return on Invested Capital (ROIC) | 16.55% |
| Return on Capital Employed (ROCE) | 15.58% |
| Weighted Average Cost of Capital (WACC) | 5.26% |
| Revenue Per Employee | 1.62M |
| Profits Per Employee | 27,468 |
| Employee Count | 1,888 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | -47.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.78% in the last 52 weeks. The beta is 0.18, so BIOVF's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +37.78% |
| 50-Day Moving Average | 29.87 |
| 200-Day Moving Average | 23.91 |
| Relative Strength Index (RSI) | 75.24 |
| Average Volume (20 Days) | 531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOVF had revenue of 3.06 billion and earned 51.86 million in profits. Earnings per share was 0.15.
| Revenue | 3.06B |
| Gross Profit | 2.42B |
| Operating Income | 868.37M |
| Pretax Income | 3.69M |
| Net Income | 51.86M |
| EBITDA | 1.25B |
| EBIT | 868.37M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 112.94 million in cash and 1.25 billion in debt, with a net cash position of -1.13 billion.
| Cash & Cash Equivalents | 112.94M |
| Total Debt | 1.25B |
| Net Cash | -1.13B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.09B |
| Book Value Per Share | 11.84 |
| Working Capital | -167.19M |
Cash Flow
In the last 12 months, operating cash flow was 929.24 million and capital expenditures -4.34 million, giving a free cash flow of 924.90 million.
| Operating Cash Flow | 929.24M |
| Capital Expenditures | -4.34M |
| Free Cash Flow | 924.90M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.87%, with operating and profit margins of 28.34% and 1.69%.
| Gross Margin | 78.87% |
| Operating Margin | 28.34% |
| Pretax Margin | 0.12% |
| Profit Margin | 1.69% |
| EBITDA Margin | 40.68% |
| EBIT Margin | 28.34% |
| FCF Margin | 30.19% |
Dividends & Yields
BIOVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.59% |
| Shareholder Yield | -0.59% |
| Earnings Yield | 0.37% |
| FCF Yield | 6.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOVF has an Altman Z-Score of 3.36 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.36 |
| Piotroski F-Score | 7 |